COMMUNIQUÉS West-GlobeNewswire

Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences
08/05/2018
-- Addition of Senior Executive with Significant Process Science Experience Supports Company’s Efforts to Expand and Enhance Process Development Capabilities -- TUSTIN, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Avid [...]
First Choice Healthcare Solutions to Report First Quarter 2018 Results on May 9, 2018
08/05/2018
MELBOURNE, Fla., May 08, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018
08/05/2018
SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
08/05/2018
AUSTIN, Texas, May 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Athenex to Present at Deutsche Bank’s 43rd Annual Health Care Conference
08/05/2018
BUFFALO, N.Y., May 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Daré Bioscience, Inc. Expands Leadership Team, Appointing John Fair to Chief Business Officer
08/05/2018
SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced it has appointed Mr. Fair to the newly created position of Chief [...]
Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
08/05/2018
-- Initiated Phase 3 Study URIROX-1™ and Phase 2 Study 206 for ALLN-177 in Patients with Severe Hyperoxaluria -- -- Reiterates Guidance for Key Objectives Across Portfolio-- NEWTON, Mass., May 08, 2018 (GLOBE NEWSWIRE [...]
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018
08/05/2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI ) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 [...]
iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018
08/05/2018
NASHUA, N.H., May 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of [...]
Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food
08/05/2018
Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood potassium) – a chronic, asymptomatic condition that often coexists with other disorders, including chronic kidney [...]
Sim Farar Joins BioSig Technologies Advisory Board
08/05/2018
Los Angeles based business leader and political adviser to support strategic plans Santa Monica, CA, May 08, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a [...]
Golden Leaf Holdings to Present at Canaccord Genuity's 2nd Annual Cannabis Conference
08/05/2018
PORTLAND, Ore., May 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
PCI Biotech: Notice of Annual General Meeting 2018
08/05/2018
Oslo, Norway 8 May 2018 - The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2018 at Oslo Cancer Cluster Innovation Park. Time: Monday May 29, 10am CEST (local time). Venue: [...]
Horizon Discovery Group plc: Preliminary Results for the Year Ended 31 December 2017
08/05/2018
Horizon Discovery Group plc ("Horizon" or "the Company" or "the Group") Preliminary Results for the Year Ended 31 December 2017 Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD), a global leader in gene [...]
Horizon Discovery Group plc: Revenue Multiple Represented by the Value of Abcam's Unsolicited Proposal
08/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]
Horizon Discovery appoints Terry Pizzie as Chief Executive Officer
08/05/2018
Horizon Discovery Group plc Horizon Discovery appoints Terry Pizzie as Chief Executive Officer Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a global leader [...]
Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator
08/05/2018
Leading Surgeon and Researcher in Islet Transplantation at the University of Chicago to act as Clinical Trial Principal Investigator. Study to focus on severely diabetic patients with hypoglycemia unawareness LONDON, [...]
CureVac Announces New Management Structure
08/05/2018
Founder Ingmar Hoerr to transition to Chairman role; Daniel Menichella to become CEO TÜBINGEN, Germany and BOSTON, May 08, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the [...]
Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations
08/05/2018
SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc. announced today that they have submitted to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Administration ( [...]

Pages